ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

Home-Based Program Helps Older Cancer Survivors

May 29, 2009

New Treatment Approach To Treating Brain Tumor

April 26, 2002

NCI Programs: BSA Approves $30M 5-Year Set-Aside For Leadership Initiative On Cancer

November 20, 1998

I-ELCAP: NEJM And Other Journals Seek Information On The Study’s Confidential Review From Henschke And Her Employers

May 6, 2011

DCE Board Approves Recompetition Concepts

March 18, 1988

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981